Current Value of Holding

$364 Million

Shares

4.26 Million

% of Portfolio

0.37%

Average Buy Price

$68.6

Avg closing price
Price range

46 Ken Griffin Dexcom Trades

Ken Griffin's position in Dexcom is currently worth $364 Million. That's 0.37% of their equity portfolio (36th largest holding). The investor owns 1.14% of the outstanding Dexcom stock. The first Dexcom trade was made in Q2 2013. Since then Ken Griffin bought shares 64 more times and sold shares on 47 occasions. The stake costed the investor $292 Million, netting the investor a gain of 24% so far.

Avg closing price
Price range
Increased shares by 245.4% (+3.03 Million shares) Q4 2024
Avg closing price $74.39
Price range $65.68 - $81.01
Increased shares by 69.5% (+506 Thousand shares) Q3 2024
Avg closing price $82.36
Price range $64.00 - $116.06
Increased shares by 5.1% (+35.5 Thousand shares) Q2 2024
Avg closing price $126.43
Price range $110.31 - $140.45
Sold 70.9% shares (-1.68 Million shares) Q1 2024
Avg closing price $125.70
Price range $114.22 - $140.10
Increased shares by 151.8% (+1.43 Million shares) Q4 2023
Avg closing price $102.16
Price range $75.49 - $124.16
Increased shares by 265.7% (+686 Thousand shares) Q3 2023
Avg closing price $112.73
Price range $86.06 - $137.93
Sold 93.6% shares (-3.78 Million shares) Q2 2023
Avg closing price $120.95
Price range $112.47 - $130.98
Increased shares by 80.9% (+1.81 Million shares) Q1 2023
Avg closing price $111.94
Price range $104.00 - $122.92
Increased shares by 243.8% (+1.58 Million shares) Q4 2022
Avg closing price $109.79
Price range $84.98 - $122.67
Sold 78.8% shares (-2.42 Million shares) Q3 2022
Avg closing price $84.70
Price range $76.35 - $94.18
Increased shares by 145.2% (+1.82 Million shares) Q2 2022
Avg closing price $91.26
Price range $67.99 - $132.89
Increased shares by 110.2% (+657 Thousand shares) Q1 2022
Avg closing price $109.39
Price range $94.08 - $130.20
Sold 19.0% shares (-140 Thousand shares) Q4 2021
Avg closing price $143.69
Price range $129.87 - $162.82
Increased shares by 4154.8% (+718 Thousand shares) Q3 2021
Avg closing price $126.11
Price range $106.71 - $143.18
Sold 96.6% shares (-490 Thousand shares) Q2 2021
Avg closing price $96.03
Price range $80.99 - $107.93
Sold 9.4% shares (-52.6 Thousand shares) Q1 2021
Avg closing price $93.87
Price range $84.79 - $104.74
Sold 21.8% shares (-157 Thousand shares) Q3 2020
Avg closing price $104.48
Price range $95.51 - $112.95
Sold 46.8% shares (-630 Thousand shares) Q2 2020
Avg closing price $89.45
Price range $62.68 - $105.34
Sold 22.5% shares (-390 Thousand shares) Q1 2020
Avg closing price $62.22
Price range $47.79 - $75.63
Increased shares by 277.2% (+1.28 Million shares) Q4 2019
Avg closing price $47.43
Price range $36.62 - $57.30

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!